2Nakamoto YJ,Chin BB,Kraitchman DL,et al.Effects of nonionic intravenous contrast agents at PET-CT imaging:phantom and canine studies[J].Radiol,2003,227(3):817-824.
3Kamimura H,Mochiki E,Kamiyama Y,et al.Gastrointestinal stromal tumor of the stomach:report of a case[J].Hepatogastroenterology,2005,52(64):1297-1300.
4Stahl A,Ott K,Weber WA,et al.FDG PET imaging of locally advanced gastric carcinomas:correlation with endoscopic and histopathological findings[J].Eur J Nucl Med Mol Imaging,2003,30(2):288-295.
5Mochiki E,Kuwano H,Katoh H,et al.Evaluation of 18 F-2-deoxy-2-fluoro-D-glucose positron emission tomography for gastric cancer[J].World J Surg,2004,28(3):247-253.
6Yoshioka T,Yamaguchi K,Kubota K,et al.Evaluation of 18 F FDGPET in patients with advanced,metastatic,or recurrent gastric cancer[J].J Nucl Med,2003,44(5):690-699.
7Chahlavi A,Staugaitis SM,Yahya R,et al.Intracranial collision tumor mimicking an octreotide-SPECT positive and FDG-PET negative meningioma[J].J Clin Neurosci,2005,12(6):720-723.
8吴阶平 裘法祖.黄家驷外科学[M](第6版)[M].北京:人民卫生出版社,2000.1269.
9吴阶平 裘法祖.黄家驷外科学[M]6版[M].北京:人民卫生出版社,2000.954-955.
10Shreve PD,Steventon RS,Deters EC,et al.Oncologic diagnosis with 2-[fluorine-18] fluoro-2-deoxy-D-glucose imaging:dual-head coincidence gamma camera versus positron emission tomographic scanner[J].Radiology,1998,207(2):431-437.
